Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous versus intermittent vancomycin infusion for dose adjustment
TCTR20210122005Phase 4Completed
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Jul 2021
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in bacterial disease, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Jul 2021; status: completed.
02
Drugs
vancomycin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on TCTR20210122005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210122005.